MOGAD Awareness Month 2025: MOGAD Mimickers

Hesham Abboud

Multiple Sclerosis Treatment

ZINCARE

M. Chomba

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

The Role of B Cells in Progressive MS and the Long-term Effects of B…

The France Foundation

J. Berger

Multiple Sclerosis Year in Review 2024

UF Health Norman Fixel Institute for Neurological Diseases

T. Rempe

Multiple Sclerosis for the Non-Neurologist

Providence Swedish

J. D. Bowen

Aberrant Iron Deposition in the Progressive MS Spinal Cord Relates t…

Marco Pisa

Symptomatic Management in Multiple Sclerosis

ZINCARE

A. Simpson

ECTRIMS 2024 Insights: Pathology of NMOSD, MOGAD and MS

Hans Lassmann

The Connection Between Viruses and Other Factors Contributing to the…

The France Foundation

M. Levy

Breaking Down Common But Complicated Questions in MS: Updates on Bio…

Women Neurologists Group (WNG)

E. M. Schorr

Neural effects of fatigue on cognition in relapsing MS detected by m…

2023 Conference Coverage

A. Memon

ECTRIMS 2024 Insights: Role of Diet, Vitamins and in MS

Anneke Van Der Walt

Introduction to Multiple Sclerosis

ZINCARE

M. Chomba

Multiple Sclerosis Update

Florida Society of Neurology

T. Rempe

Navigating Neurogenic Bladder and Sexual Dysfunction

Diagnosis and Management of Neurogenic Bladder and Sexual Dysfunction Video Series

T. Kaplan

Strategies to Promote Myelin Repair

OHSU

L. Wooliscroft

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

COVID-19 Vaccination and Immunotherapies for Multiple Sclerosis

University of Miami

K. Rammohan

Highlights on Multiple Sclerosis: Topographical Model of MS and JC V…

2023 Conference Coverage

S. Krieger